You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LGND Exercise Disclosure
Reardon Andrew · SEC Form 4 · Filed Jul 6, 2026
Exercise
Calculated transaction value
$0
Reardon Andrew CLO & Secretary
LGND
Transaction date
Jul 1, 2026
Public filing date
Jul 6, 2026
Filing lag
Filed 5 days later
LGND daily price context
Close on/before transaction
$312.01
Jul 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Common Stock
- Quantity / price
- 5,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002001011-26-000108
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$1.85M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ligand Pharmaceuticals Inc LGND Current | Exercise | Jul 1, 2026 | $0 |
| Ligand Pharmaceuticals Inc LGND | Exercise | Jul 1, 2026 | $261.35K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jul 1, 2026 | $122.36K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jul 1, 2026 | $348.81K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jul 1, 2026 | $32.26K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jul 1, 2026 | $337.57K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jul 1, 2026 | $219.42K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jul 1, 2026 | $31.46K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jul 1, 2026 | $284.2K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jul 1, 2026 | $190.29K |
| Ligand Pharmaceuticals Inc LGND | Other | Jun 30, 2026 | $21.21K |